Shop by goal

Popular compounds

GHK-Cu

Retatrutide

Research resources

Certificates of Analysis

Glow: Stacks research guide

In short: Glow is a three-compound research blend combining GHK-Cu, BPC-157 and TB-500 in a single vial - the copper-binding tripeptide paired with the two most-studied tissue-repair peptides. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

Not medical advice. Glow is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

Glow at a glance

Compound type

Research peptide

Research category

Stacks

Also known as

GLOW stack, GLOW blend, GHK-Cu + BPC-157 + TB-500, skin and recovery stack, tri-peptide blend

Research-grade purity

>99% HPLC (per component)

Evidence context

Preclinical / research use only

Regulatory status

Not an approved medicine. Supplied as a research compound

Last reviewed

29 July 2026

What to know first

Three research compounds pre-combined in a single vial - one reconstitution instead of three

GHK-Cu (50 mg): copper-binding tripeptide studied for matrix remodelling and collagen signalling

BPC-157 (10 mg): pentadecapeptide studied for angiogenic and tissue-repair pathways

TB-500 (10 mg): thymosin beta-4 fragment studied for actin binding and cell migration

Details and limits sit in the sections below. Research use only.

What Glow is

Glow is a fixed research blend of GHK-Cu, BPC-157 and TB-500 - 70 mg of total peptide per vial, combining the copper tripeptide with the two most-studied tissue-repair compounds.

One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

Glow is a three-compound research blend combining GHK-Cu, BPC-157 and TB-500 in a single vial - the copper-binding tripeptide paired with the two most-studied tissue-repair peptides.

Research contexts

Peer-reviewed papers discuss Glow in specific lab settings. The points below reflect research questions, not health claims.

Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

Typical study contexts

Component peptides are usually characterised individually first; combination papers are less common.

Three research compounds pre-combined in a single vial - one reconstitution instead of three.

GHK-Cu (50 mg): copper-binding tripeptide studied for matrix remodelling and collagen signalling.

BPC-157 (10 mg): pentadecapeptide studied for angiogenic and tissue-repair pathways.

TB-500 (10 mg): thymosin beta-4 fragment studied for actin binding and cell migration.

Why Stacks research matters

Stack products combine research peptides. Guides note how components are usually studied alone first.

Mechanisms (technical review)

Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

Three research compounds pre-combined in a single vial - one reconstitution instead of three

GHK-Cu (50 mg): copper-binding tripeptide studied for matrix remodelling and collagen signalling

BPC-157 (10 mg): pentadecapeptide studied for angiogenic and tissue-repair pathways

TB-500 (10 mg): thymosin beta-4 fragment studied for actin binding and cell migration

Removes the compounding-error risk of measuring three separate powders

Each component is independently available, so the blend can be benchmarked against its parts

Lab handling & preparation

Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.

Research dosing context: Literature typically discusses Research protocols for the blend follow the component literature rather than a combined schedule. Component studies commonly use daily or alternate-day subcutaneous administration in short cycles No pharmacokinetic study exists for the three compounds administered as a fixed blend - the components have distinct half-lives and clearance routes, and combining them does not create a shared profile. Any protocol should be derived from the individual GHK-Cu, BPC-157 and TB-500 literature, treating the blend purely as a delivery convenience. These figures describe the published component research and are not a dosing recommendation.

Preparation: Follow the reconstitution guide. Confirm volumes with the calculator.

Purity check: Use the COA reading guide and the published Glow Certificate of Analysis.

Common Questions People Are Asking

What is in the Glow stack?

Each vial contains GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg - 70 mg of total peptide. The ratio is fixed across every vial in the pack. All three components are also available individually, so the blend can be benchmarked against its parts.

Why buy a blend instead of the three compounds separately?

Purely for handling. A fixed blend means one reconstitution step instead of three, which removes two weighing operations and the compounding error that comes with them. There is no pharmacological argument for the combination - the components retain their individual half-lives and clearance routes whether they share a vial or not.

Is there research on the three compounds used together?

No. No pharmacokinetic, safety or efficacy study has examined GHK-Cu, BPC-157 and TB-500 administered as a fixed blend, and no interaction data exists. The individual components have their own literatures - GHK-Cu's dermal and matrix-biology work is the most substantial - but component evidence does not transfer to a combination. Design protocols from the component literature.

How does Glow differ from Klow?

Klow is the same three compounds plus KPV at 10 mg, bringing the total to 80 mg per vial. KPV is the C-terminal tripeptide fragment of alpha-MSH, studied for anti-inflammatory signalling. Otherwise the GHK-Cu, BPC-157 and TB-500 quantities are identical between the two blends.

How should the Glow stack be stored?

Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water or sterile saline, refrigerate at 1–6 °C and protect from light. Because the vial contains three compounds with different stability characteristics, use it within the validated window for the batch rather than extrapolating from any single component.

Is this page medical advice? Can I use Glow for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find Glow specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

Related peptide guides

Other compounds researchers often read about alongside Glow.

GHK-Cu - companion guide

BPC-157 - companion guide

TB-500 - companion guide

Klow - companion guide

Scientific sources & further reading

Primary literature and registries for Glow, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on Glow

ClinicalTrials.gov: registered studies on Glow

Glow: Wikipedia (search)

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: GLOW stack, GLOW blend, GHK-Cu + BPC-157 + TB-500, skin and recovery stack, tri-peptide blend

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research